CN116064344A - Construction method and application of recombinant escherichia coli for producing hydroxytyrosol by fermentation - Google Patents
Construction method and application of recombinant escherichia coli for producing hydroxytyrosol by fermentation Download PDFInfo
- Publication number
- CN116064344A CN116064344A CN202210930591.7A CN202210930591A CN116064344A CN 116064344 A CN116064344 A CN 116064344A CN 202210930591 A CN202210930591 A CN 202210930591A CN 116064344 A CN116064344 A CN 116064344A
- Authority
- CN
- China
- Prior art keywords
- hydroxytyrosol
- escherichia coli
- recombinant
- prsfduet
- petduet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- JUUBCHWRXWPFFH-UHFFFAOYSA-N Hydroxytyrosol Chemical compound OCCC1=CC=C(O)C(O)=C1 JUUBCHWRXWPFFH-UHFFFAOYSA-N 0.000 title claims abstract description 122
- 235000003248 hydroxytyrosol Nutrition 0.000 title claims abstract description 59
- 229940095066 hydroxytyrosol Drugs 0.000 title claims abstract description 59
- 241000588724 Escherichia coli Species 0.000 title claims abstract description 47
- 238000000855 fermentation Methods 0.000 title claims abstract description 27
- 230000004151 fermentation Effects 0.000 title claims abstract description 27
- 238000010276 construction Methods 0.000 title claims abstract description 10
- 239000013612 plasmid Substances 0.000 claims abstract description 36
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 23
- 238000012258 culturing Methods 0.000 claims abstract description 9
- 230000006698 induction Effects 0.000 claims abstract description 5
- 238000004811 liquid chromatography Methods 0.000 claims abstract description 4
- 238000009825 accumulation Methods 0.000 claims abstract description 3
- 239000000411 inducer Substances 0.000 claims abstract description 3
- 239000012634 fragment Substances 0.000 claims description 15
- 239000013598 vector Substances 0.000 claims description 15
- 239000001963 growth medium Substances 0.000 claims description 10
- 230000006801 homologous recombination Effects 0.000 claims description 10
- 238000002744 homologous recombination Methods 0.000 claims description 10
- 238000012408 PCR amplification Methods 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 238000012262 fermentative production Methods 0.000 claims description 5
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 claims description 4
- 101150067366 adh gene Proteins 0.000 claims description 4
- 108010021809 Alcohol dehydrogenase Proteins 0.000 claims description 3
- 102000007698 Alcohol dehydrogenase Human genes 0.000 claims description 2
- 101710118140 Alpha-keto-acid decarboxylase Proteins 0.000 claims description 2
- 108010000898 Chorismate mutase Proteins 0.000 claims description 2
- 101710088194 Dehydrogenase Proteins 0.000 claims description 2
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 claims description 2
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 claims description 2
- 150000007649 L alpha amino acids Chemical class 0.000 claims description 2
- 102000008109 Mixed Function Oxygenases Human genes 0.000 claims description 2
- 108010074633 Mixed Function Oxygenases Proteins 0.000 claims description 2
- 101100216804 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ARO10 gene Proteins 0.000 claims description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 2
- 230000004927 fusion Effects 0.000 claims description 2
- 239000002054 inoculum Substances 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 14
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract description 12
- 230000037361 pathway Effects 0.000 abstract description 8
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract description 8
- 238000003786 synthesis reaction Methods 0.000 abstract description 7
- 230000002194 synthesizing effect Effects 0.000 abstract description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 4
- 229910052799 carbon Inorganic materials 0.000 abstract description 4
- 230000006872 improvement Effects 0.000 abstract description 3
- 238000011081 inoculation Methods 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 17
- YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-Hydroxyphenyl)ethanol Natural products OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 description 15
- 239000007788 liquid Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- 239000002609 medium Substances 0.000 description 9
- DBLDQZASZZMNSL-QMMMGPOBSA-N L-tyrosinol Natural products OC[C@@H](N)CC1=CC=C(O)C=C1 DBLDQZASZZMNSL-QMMMGPOBSA-N 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 235000004330 tyrosol Nutrition 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 229960004441 tyrosine Drugs 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- RFWGABANNQMHMZ-UHFFFAOYSA-N 8-acetoxy-7-acetyl-6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4',5':4,5]benzo[1,2,3-de]quinoline Natural products CC=C1C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O RFWGABANNQMHMZ-UHFFFAOYSA-N 0.000 description 5
- HKVGJQVJNQRJPO-UHFFFAOYSA-N Demethyloleuropein Natural products O1C=C(C(O)=O)C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(=CC)C1OC1OC(CO)C(O)C(O)C1O HKVGJQVJNQRJPO-UHFFFAOYSA-N 0.000 description 5
- RFWGABANNQMHMZ-HYYSZPHDSA-N Oleuropein Chemical compound O([C@@H]1OC=C([C@H](C1=CC)CC(=O)OCCC=1C=C(O)C(O)=CC=1)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RFWGABANNQMHMZ-HYYSZPHDSA-N 0.000 description 5
- 229960000723 ampicillin Drugs 0.000 description 5
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 5
- 229930182823 kanamycin A Natural products 0.000 description 5
- 235000011576 oleuropein Nutrition 0.000 description 5
- RFWGABANNQMHMZ-CARRXEGNSA-N oleuropein Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)C(=CC)[C@H]1CC(=O)OCCc3ccc(O)c(O)c3 RFWGABANNQMHMZ-CARRXEGNSA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000007664 blowing Methods 0.000 description 3
- 235000010410 calcium alginate Nutrition 0.000 description 3
- 239000000648 calcium alginate Substances 0.000 description 3
- 229960002681 calcium alginate Drugs 0.000 description 3
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- -1 polyphenol compound Chemical class 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 101150037691 ARO10 gene Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000672609 Escherichia coli BL21 Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 241000607720 Serratia Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- NOIIUHRQUVNIDD-UHFFFAOYSA-N 3-[[oxo(pyridin-4-yl)methyl]hydrazo]-N-(phenylmethyl)propanamide Chemical compound C=1C=CC=CC=1CNC(=O)CCNNC(=O)C1=CC=NC=C1 NOIIUHRQUVNIDD-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 1
- 102000010911 Enzyme Precursors Human genes 0.000 description 1
- 108010062466 Enzyme Precursors Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000589776 Pseudomonas putida Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 description 1
- 102000048218 Tyrosine 3-monooxygenases Human genes 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000002210 biocatalytic effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000008832 photodamage Effects 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01001—Alcohol dehydrogenase (1.1.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/14—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen (1.14.14)
- C12Y114/14009—4-Hydroxyphenylacetate 3-monooxygenase (1.14.14.9)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y205/00—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
- C12Y205/01—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
- C12Y205/01054—3-Deoxy-7-phosphoheptulonate synthase (2.5.1.54)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/01—Carboxy-lyases (4.1.1)
- C12Y401/01043—Phenylpyruvate decarboxylase (4.1.1.43)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y504/00—Intramolecular transferases (5.4)
- C12Y504/99—Intramolecular transferases (5.4) transferring other groups (5.4.99)
- C12Y504/99005—Chorismate mutase (5.4.99.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/101—Plasmid DNA for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to a technical improvement of biosynthesis of hydroxytyrosol, in particular to a construction method and application of recombinant escherichia coli for producing hydroxytyrosol by fermentation, and a way for synthesizing hydroxytyrosol from a simple carbon source is realized; culturing recombinant E.coli BLAH carrying plasmids pRSFDuet-HpaBC-LAAD-ARO10-ADH and pETDuet-AROG-TYRA and recombinant E.coli BLCK carrying plasmids pRSFDuet-1 and pETDuet-1 in LB medium; inoculating the strain into TB culture solution according to the inoculation amount of 0.5-2%, performing expansion culture, adding 0.1-0.3 mM inducer for induction culture, continuously culturing at 30 ℃ and 220r/min for product accumulation, and detecting the hydroxytyrosol yield by liquid chromatography every 8 hours. As the simplest model organism, the background is clear, the growth is quick, the large-scale fermentation culture is easy, and the cost is low; and the key genes in the endogenous synthesis tyrosine pathway of the escherichia coli are over-expressed, and the heterologous genes for synthesizing the hydroxytyrosol from the tyrosine are introduced into the escherichia coli host for accumulating the tyrosine, so that the pathway for synthesizing the hydroxytyrosol from a simple carbon source is constructed.
Description
Technical Field
The invention relates to a technical improvement of biosynthesis of hydroxytyrosol, in particular to a construction method and application of recombinant escherichia coli for producing hydroxytyrosol by fermentation.
Background
Hydroxytyrosol (HT), also known as 3, 4-dihydroxyphenethyl alcohol (3, 4-dihydroxyphenethyl alcohol), has a molecular weight of 154.164 and a molecular formula of C 8 H 10 O 3 Is a natural polyphenol compound with various biological and pharmacological activities. The hydroxytyrosol has strong antioxidant effect, and can transfer the hydrogen of the phenolic hydroxyl to active oxygen, so that the damage of hydrogen peroxide in human red blood cells to DNA and cell membranes can be protected, free radicals generated under ultraviolet irradiation can be removed, and the photodamage of skin can be protected. Hydroxytyrosol has antiinflammatory activity, can reduce gene expression related to inflammation, has antitumor effect, can promote apoptosis and antibacterial activity of cancer cells by activating molecular signal transduction, has effect of inhibiting microbial activity, and has antibacterial effect on various strains in intestinal tract. Therefore, hydroxytyrosol has wide application in cosmetics, pharmaceutical industry and health food. Currently commercialized hydroxytyrosol is mainly extracted from natural plants or obtained by chemical synthesis. In nature, hydroxytyrosol is present in large amounts in olive leaves and fruits, and can be obtained by hydrolysis of oleuropein and extraction from olive oil or waste water from the olive oil production process。
Despite the abundance and low cost of olive related sources of raw materials, the method of extraction from plants still has the following drawbacks: the operation process is complex, the recovery rate is low, the energy consumption is high, the strong acidity is realized, and the time is long. The hydroxytyrosol can also be synthesized by a chemical method, but the method has the problems of higher substrate cost, complex process, severe conditions, environmental pollution, solvent residues and the like, and is difficult to produce in batches. Therefore, the hydroxyl tyrosol with high added value is efficiently produced by using cheap raw materials through a biosynthesis way, which is beneficial to promoting the industrialized development of the hydroxyl tyrosol.
The biosynthesis of hydroxytyrosol has been studied: santos et al used lactic acid bacteria to degrade oleuropein to synthesize hydroxytyrosol, tested the degradation efficiency of six bacteria on oleuropein under aerobic and anaerobic conditions, and found that the most effective strain was Lactobacillus plantarum 6907, the degradation rate on oleuropein can reach 90%, but the conversion rate of oleuropein into hydroxytyrosol is only 30%; allouche et al utilize Serratia viscosa and Pseudomonas aeruginosa to synthesize hydroxytyrosol through tyrosol isomers, use calcium alginate hydrogel as carrier, apply microorganism solid phase loading technology, carry Serratia viscosa and Pseudomonas aeruginosa on the carrier, then catalyze tyrosol to produce hydroxytyrosol through two kinds of cells carried on the carrier, result shows that the carrier can use 4g/L tyrosol solution as substrate to produce hydroxytyrosol, the product conversion rate reaches 82%; brooks et al use Pseudomonas putida expressing tyrosinase activity to catalyze tyrosol to synthesize hydroxytyrosol, and the yield reaches 77%; the stationary cells of the pseudomonas aeruginosa in the calcium alginate beads are immobilized on the calcium alginate hydrogel by using a microorganism solid phase loading technology, such as Boua gui, and 5g/L tyrosol can be used as a substrate to generate hydroxytyrosol, and the product conversion rate reaches 86%. In the research of the biosynthesis of hydroxytyrosol, tyrosol is used as a substrate, so that the cost is high, and mass production is difficult. Satoh et al studied the way of biosynthesis of hydroxytyrosol using L-tyrosine as substrate, tyrosine was hydroxylated by mouse-derived tyrosine hydroxylase in the presence of cofactor tetrahydrobrowning protein, but tetrahydrobrowning protein is not currently available commercially, thus severely limiting the biocatalytic efficiency of key enzymes in this way, and studied the production of hydroxytyrosol using glucose as a raw material, with a final hydroxytyrosol content of 12.3mg/L. Li et al synthesized intermediate tyrosol with L-tyrosine as substrate, and then further synthesized hydroxytyrosol with a yield close to 50%. Chen et al studied two mixed pathways for producing hydroxytyrosol using tyrosine as substrate, the synthesis capacity was significantly improved when both pathways acted simultaneously compared to each individual pathway, and the final hydroxytyrosol yield was 1.89g/L by fed-batch fermentation.
Therefore, it can be seen from the above that the prior art method for biosynthesis of hydroxytyrosol is feasible, but how to realize high yield of hydroxytyrosol in the biosynthesis mode is still a technical problem to be solved.
Disclosure of Invention
The invention aims to overcome the existing defects, and provides a construction method and application of recombinant escherichia coli for producing hydroxytyrosol by fermentation, so as to realize a way of synthesizing hydroxytyrosol from a simple carbon source.
In order to solve the technical problems, the invention provides the following technical scheme: the construction method of recombinant escherichia coli for producing hydroxytyrosol by fermentation comprises the following steps of firstly, obtaining HpaBC and LAAD genes and linearized pRSFDuet-1 vector fragments by PCR amplification, and fusing the fragments by homologous recombination to obtain plasmid pRSFDuet-HpaBC-LAAD; PCR amplification to obtain ARO10, ADH gene and pRSFDuet-HpaBC-LAAD vector fragment, and fusion of these fragments by homologous recombination to obtain plasmid pRSFDuet-HpaBC-LAAD-ARO10-ADH; PCR amplification to obtain AROG and TYRA genes and linearized pETDuet-1 vector fragments, and fusing the fragments through homologous recombination to obtain plasmid pETDuet-AROG-TYRA;
step two, the plasmid pRSFDuet-HpaBC-LAAD-ARO10-ADH and the plasmid pETDuet-AROG-TYRA are jointly transferred into competent cells of the escherichia coli BL21 (DE 3) to obtain recombinant escherichia coli BLAH, and the plasmids pRSFDuet-1 and pETDuet-1 are jointly transferred into competent cells of the escherichia coli BL21 (DE 3) to obtain recombinant escherichia coli BLCK.
In order to solve the technical problems, the invention provides the following technical scheme: the use of recombinant E.coli for fermentative production of hydroxytyrosol, the recombinant E.coli according to claim 1 being used for fermentative production of hydroxytyrosol.
Preferably, 6 enzymes are expressed by recombinant E.coli: hydroxylase, L-alpha-amino acid deaminase, alpha-keto acid decarboxylase, alcohol dehydrogenase, 2-dehydro-3-deoxyphosphoheptylaldehyde aldolase and chorismate mutase/benzoate dehydrogenase.
Preferably, the recombinant E.coli production method comprises the following steps,
step one, culturing recombinant escherichia coli BLH carrying plasmids pRSFDuet-HpaBC-LAAD-ARO10-ADH and pETDuet-AROG-TYRA and recombinant escherichia coli BLCK carrying plasmids pRSFDuet-1 and pETDuet-1 in an LB culture medium;
and step two, inoculating the strain into TB culture solution according to the inoculum size of 0.5-2% for expansion culture, then adding an inducer of 0.1-0.3 mM for induction culture, continuously culturing at 30 ℃ and 220r/min for product accumulation, and detecting the hydroxytyrosol yield by liquid chromatography every 8 hours.
The invention has the beneficial effects that: the escherichia coli is used as a zymogen for producing hydroxytyrosol by fermentation and is used as the simplest model organism, the background is clear, the growth is quick, the large-scale fermentation culture is easy, and the cost is low; and the key genes in the endogenous synthesis tyrosine pathway of the escherichia coli are over-expressed, and the heterologous genes for synthesizing the hydroxytyrosol from the tyrosine are introduced into the host of the escherichia coli for accumulating the tyrosine, so that the pathway for synthesizing the hydroxytyrosol from a simple carbon source is constructed, and the amplified production is carried out at the level of a 5-L fermentation tank, thereby realizing the de-novo synthesis of the hydroxytyrosol in the escherichia coli, remarkably improving the yield of the hydroxytyrosol and laying a foundation for the large-scale industrial production and application of the hydroxytyrosol.
Drawings
FIG. 1 is a diagram of the enzymatic synthesis of hydroxytyrosol pathway for HpaBC, LAAD, ARO, ADH, AROG and TYRC enzymes according to an embodiment of the present invention;
FIG. 2 is a graph showing the time profile of production of hydroxytyrosol by recombinant E.coli strain BLAH in a 5-L fermenter according to an embodiment of the present invention;
FIG. 3 is a diagram showing HPLC verification of a catalytic reaction of recombinant E.coli strain BLAH with glucose as a substrate for 48h according to an embodiment of the present invention.
Detailed Description
The preferred embodiments of the present invention will be described below with reference to the accompanying drawings, it being understood that the preferred embodiments described herein are for illustration and explanation of the present invention only, and are not intended to limit the present invention.
The test materials adopted by the invention are all common commercial products and can be purchased in the market; the related experiments are conventional experiments unless otherwise specified.
The sources of the materials are as follows: coli strains BL21 (DE 3) and JM109 are commercially available, E.coli strain BL21 (DE 3) is used for expression of all genes in the present invention, JM109 is used for vector construction. Coli expression vectors pETDuet-1, pRSFDuet-1 were derived from Novagen, primerSTAR high-fidelity DNA polymerase, restriction enzymes and E.coli competent preparation kit purchased from Bao Ri doctor Material technology (Beijing) Co. Plasmid extraction kit, DNA purification kit and gel recovery kit, ampicillin, kanamycin, isopropyl-beta-D-thiogalactoside (IPTG) were purchased from Shanghai bioengineering Co., ltd. Yeast powder, peptone in this study were purchased from Oxoid Co., ltd. All chemical reagents were purchased from the national drug group and were all analytically pure and above.
The LB medium consists of: 10g/L peptone, 5g/L yeast powder, 5g/L NaCl, and the balance of double distilled water, and sterilizing at 121 ℃ for 20min.
The composition of the TB medium is: 12g/L peptone, 24g/L yeast powder, 2.31g/L KH2PO4, 12.54g/L K HPO4, 0.4% glycerol, and the balance double distilled water, and sterilizing the culture medium at 121deg.C for 20min.
Example 1 construction of recombinant E.coli BLAH and BLCK;
1. acquisition of the target gene: the target gene sequence is shown in SEQ ID NO 1-SEQ ID NO 7, and gene synthesis is carried out by Tianlin biotechnology (Shanghai) limited company; the target gene is amplified by a PrimeSTAR DNA Polymerase high-fidelity enzyme through a PCR system of 50 mu l standard system, and the amplification conditions are as follows: pre-denaturing at 95 ℃ for 30s, annealing at 58 ℃ for 45s, extending at 72 ℃ for 1min for 30s, performing 25 cycles, extending at 72 ℃ for 10min, performing nucleic acid electrophoresis on the PCR product, purifying, connecting the PCR product with a carrier, converting the PCR product into competent cells of Escherichia coli JM109, picking up positive transformants, extracting plasmids, and sending the plasmids to Suzhou gold intelligent biotechnology company for sequencing;
2. preparation of E.coli competence: dipping a small amount of bacterial liquid from the frozen tube bacteria by using a sterile inoculating loop, streaking on a non-resistant LB solid culture medium plate, and placing the plate at 37 ℃ for inverted culture for 12 hours; after colonies growing on the plates, single colonies are picked by a sterile inoculating loop and transferred into a 50mL conical flask filled with 10mL LB liquid medium, and the colonies are cultured at 37 ℃ and 180r/min overnight; activating strains in 10mL of LB liquid medium, inoculating 10 mu L of bacterial liquid into a 250mL conical flask containing 50mL of LB liquid medium by using a sterile pipettor, culturing until OD600 is about 0.6, and then placing the conical flask containing bacterial liquid and a 50mL sterile centrifuge tube on ice for 30min for precooling; transferring the bacterial liquid into a 50m L centrifuge tube after precooling is finished, centrifuging for 5min at 8000r/min and 4 ℃ and collecting bacterial bodies; removing the supernatant, removing the residual culture medium with a liquid transfer device as much as possible, adding 2000 mu L of Solution A, slowly blowing and sucking to uniformly disperse the thalli in the Solution A, centrifuging at 8000r/min and 4 ℃ for 1min; removing the supernatant, carefully removing residual Solution A by a pipette, adding 2000 mu L of Solution B, gently blowing and sucking by using Solution B, and subpackaging 100 mu L of resuspended bacterial liquid by each 1.5mL EP tube to obtain competent cells;
3. construction of recombinant plasmid pRSFDuet-HpaBC-LAAD-ARO10-ADH: the HpaBC gene is obtained by respectively taking sequences shown in SEQ ID NO. 1 and SEQ ID NO. 2 as templates, taking HpaBC-F1/HpaBC-R1 and HpaBC-F2/HpaBC-R2 as primers and carrying out overlapping extension on the two sections of genes; amplifying by using a sequence shown in SEQ ID NO. 3 as a template and LAAD-F/LAAD-R as a primer to obtain a LAAD gene; amplifying pRSFDuet-1 plasmid serving as a template and pRSFDuet-F1/pRSFDuet-R1 serving as a primer to obtain a linearization vector pRSFDuet-1; carrying out three-segment homologous recombination connection on the two gene segments and the linearization vector segment, converting JM109 competent cells, and extracting plasmids to obtain recombinant plasmids pRSFDuet-HpaBC-LAAD; amplifying by using a sequence shown in SEQ ID NO. 4 as a template and ARO10-F/ARO10-R as a primer to obtain an ARO10 gene; amplifying by using a sequence shown in SEQ ID NO. 5 as a template and ADH-F/ADH-R as a primer to obtain an ADH gene; amplifying pRSFDuet-HpaBC-LAAD by taking pRSFDuet-F2/pRSFDuet-R2 as a primer to obtain a linearization vector pRSFDuet-HpaBC-LAAD; carrying out three-fragment homologous recombination connection on the obtained ARO10 gene, ADH gene and pRSFDuet-HpaBC-LAAD linearization vector, converting JM109 competent cells, and extracting plasmids to obtain recombinant plasmid pRSFDuet-HpaBC-LAAD-ARO10-ADH;
4. constructing a recombinant plasmid pETDuet-AROG-TYRA: amplifying by using a sequence shown in SEQ ID NO. 6 as a template and AROG-F/AROG-R as a primer to obtain an AROG gene; amplifying by taking the pETDuet-1 plasmid as a template and pETDuet-F1/pETDuet-R1 as a primer to obtain a linearization vector pETDuet-1; carrying out homologous recombination connection on the AROG gene fragment and the linearization vector fragment obtained in the above way, converting JM109 competent cells, and extracting plasmids to obtain recombinant plasmids pETDuet-AROG; amplifying by using a sequence shown in SEQ ID NO. 7 as a template and TYRA-F/TYRA-R as a primer to obtain TYRA genes; amplifying by using pETDuet-AROG plasmid as a template and pETDuet-F2/pETDuet-R2 as a primer to obtain a linearization vector pETDuet-AROG; carrying out homologous recombination connection on the TYRA gene and the pETDuet-AROG linearization vector, converting into competent cells of escherichia coli JM109, and extracting plasmids to obtain recombinant plasmids pETDuet-AROG-TYRA;
5. obtaining recombinant escherichia coli BLAH and BLCK, namely co-transforming the two recombinant plasmids pRSFDuet-HpaBC-LAAD-ARO10-ADH and pETDuet-AROG-TYRA obtained in the above way into escherichia coli BL21 competent cells; the transformation method is as follows: placing the freshly prepared competent cells on ice for 5min; in an ultra clean bench, 10. Mu.L of DNA for transformation is added into a 1.5mL EP tube filled with competent cells by a sterile pipette, gently sucked and mixed evenly, and then placed on ice for 30min; placing in a water bath at a temperature of 42 ℃ for heat shock for 90s, and then placing on ice for 5min; adding 900 mu L of LB liquid medium into the 1.5mL EP tube in an ultra-clean workbench by using a sterile pipette, and resuscitating for 1h by using a shaking table at 37 ℃; centrifugally collecting bacterial cells cultured in an EP tube, reserving 200 mu L of culture medium, blowing and sucking, uniformly mixing, and screening in a solid culture medium containing two antibiotics of ampicillin and kanamicin to obtain a positive clone BLAH escherichia coli recombinant strain; and co-transforming the plasmid pRSFDuet-1 and pETDuet-1 into competent cells of the escherichia coli BL21, and screening the competent cells in a culture medium containing two antibiotics of ampicillin and kanamicin to obtain a positive clone BLCK escherichia coli recombinant strain;
table 1: primers for PCR amplification
EXAMPLE 2 shake flask fermentation of recombinant E.coli BLAH and BLCK
1. Strains BLAH and BLCK were streaked on a solid LB medium plate and grown in a constant temperature incubator at 37℃for 12 hours, and then single colonies were picked up and cultured in 10mL of LB liquid medium containing 50mg/L kanamycin and 100mg/L ampicillin for 12 hours at 37℃to obtain a seed solution. Transferring the seed solution into 50mL of TB medium added with 50mg/L kanamycin and 100mg/L ampicillin according to 2% transferring amount (1 mL), carrying out shaking culture at 37 ℃ until OD600 reaches 0.7-0.8, adding IPTG with final concentration of 0.1-0.3 mM for induction, culturing at 25-30 ℃ for 24 hours, and sampling and detecting the hydroxytyrosol content in the fermentation liquor at regular intervals;
2. the High Performance Liquid Chromatography (HPLC) detection method of hydroxytyrosol comprises the steps of firstly carrying out sample treatment after sampling, carrying out metal bath treatment on fermentation liquor at 100 ℃ for 15min, centrifuging at 8000r/min for 1min, collecting supernatant, and carrying out microporous filter membrane filtration treatment on the supernatant; conditions for the detection by liquid chromatography were as follows: the mobile phase is 0.1% (w/v) formic acid, pure methanol=80:20 (v/v), the flow rate is 1mL/min, the chromatographic column is Thermo Scientific C18 (4.6X250 mm,5 μm), the column temperature is 40 ℃, the wavelength of an ultraviolet detector is 280nm, and the sample injection amount is 10 mu L;
EXAMPLE 3 5-L tank fermentation of recombinant E.coli BLAH and BLCK
Amplifying and culturing the recombinant escherichia coli in the embodiment 2 by a 5-L fermentation tank, transferring a seed culture solution into a TB culture medium with 2L liquid loading capacity according to the inoculation amount of 5-8% (v/v), controlling the fermentation temperature to be 37 ℃, controlling the pH value to be between 6.8 and 7.2, and increasing the initial rotation speed to 300r/min step by step after 3 hours to 500-600 r/min, wherein the volume of the feed culture medium is 300mL for each 1L fermentation system; when the thalli are cultured until the OD600 is about 15-20, adding IPTG with the final concentration of about 0.1-0.3 mM, and carrying out induction expression for 48 hours at the temperature of 25-30 ℃, and sampling and detecting the hydroxytyrosol content in the fermentation liquor at regular intervals;
the fermentation in the 5-L fermentation tank can monitor relevant parameters such as pH, DO and the like in the fermentation process in real time, and compared with shaking flask fermentation, the method is beneficial to industrial production, and as shown in the figure 2, BLAH is fermented in the 5-L fermentation tank, the yield of hydroxytyrosol is continuously accumulated along with the increase of time, the yield starts to increase slowly after 40 hours, and the final fermentation obtains 20.06g/L of hydroxytyrosol in 48 hours.
The above is a preferred embodiment of the present invention, and a person skilled in the art can also make alterations and modifications to the above embodiment, therefore, the present invention is not limited to the above specific embodiment, and any obvious improvements, substitutions or modifications made by the person skilled in the art on the basis of the present invention are all within the scope of the present invention.
Claims (4)
1. The construction method of the recombinant escherichia coli for producing hydroxytyrosol by fermentation is characterized by comprising the following steps of firstly, obtaining HpaBC and LAAD genes and linearized pRSFDuet-1 vector fragments by PCR amplification, and fusing the fragments by homologous recombination to obtain plasmid pRSFDuet-HpaBC-LAAD; PCR amplification to obtain ARO10, ADH gene and pRSFD uet-HpaBC-LAAD vector fragment, and fusion of these fragments by homologous recombination to obtain plasmid pRSFDuet-HpaBC-LAAD-ARO10-ADH; PCR amplification to obtain AROG and TYRA genes and linearized pETDuet-1 vector fragments, and fusing the fragments through homologous recombination to obtain plasmid pETDuet-AROG-TYRA;
step two, the plasmid pRSFDuet-HpaBC-LAAD-ARO10-ADH and the plasmid pETDuet-AROG-TYRA are jointly transferred into competent cells of the escherichia coli BL21 (DE 3) to obtain recombinant escherichia coli BLAH, and the plasmids pRSFDuet-1 and pETDuet-1 are jointly transferred into competent cells of the escherichia coli BL21 (DE 3) to obtain recombinant escherichia coli BLCK.
2. The use of recombinant E.coli for fermentative production of hydroxytyrosol, characterized in that the recombinant E.coli according to claim 1 is used for fermentative production of hydroxytyrosol.
3. Use of recombinant escherichia coli for the fermentative production of hydroxytyrosol according to claim 2, wherein 6 enzymes are expressed by the recombinant escherichia coli: hydroxylase, L-alpha-amino acid deaminase, alpha-keto acid decarboxylase, alcohol dehydrogenase, 2-dehydro-3-deoxyphosphoheptylaldehyde aldolase and chorismate mutase/benzoate dehydrogenase.
4. The use of recombinant E.coli produced by fermentation according to claim 2, wherein the recombinant E.coli production method comprises the steps of,
step one, culturing recombinant escherichia coli BLH carrying plasmids pRSFDuet-HpaBC-LAAD-ARO10-ADH and pETDuet-AROG-TYRA and recombinant escherichia coli BLCK carrying plasmids pRSFDuet-1 and pETDuet-1 in an LB culture medium;
and step two, inoculating the strain into TB culture solution according to the inoculum size of 0.5-2% for expansion culture, then adding an inducer of 0.1-0.3 mM for induction culture, continuously culturing at 30 ℃ and 220r/min for product accumulation, and detecting the hydroxytyrosol yield by liquid chromatography every 8 hours.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210930591.7A CN116064344B (en) | 2022-08-04 | 2022-08-04 | Construction method and application of recombinant escherichia coli for producing hydroxytyrosol by fermentation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210930591.7A CN116064344B (en) | 2022-08-04 | 2022-08-04 | Construction method and application of recombinant escherichia coli for producing hydroxytyrosol by fermentation |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116064344A true CN116064344A (en) | 2023-05-05 |
CN116064344B CN116064344B (en) | 2024-06-07 |
Family
ID=86182628
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210930591.7A Active CN116064344B (en) | 2022-08-04 | 2022-08-04 | Construction method and application of recombinant escherichia coli for producing hydroxytyrosol by fermentation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116064344B (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104805110A (en) * | 2015-05-13 | 2015-07-29 | 中国科学院天津工业生物技术研究所 | Recombinant escherichia coli using glucose for producing hydroxytyrosol as well as recombination method and application |
CN108753636A (en) * | 2018-06-12 | 2018-11-06 | 山东恒鲁生物科技有限公司 | A kind of yeast and construction method producing tyrosol and hydroxytyrosol |
CN111647616A (en) * | 2020-06-23 | 2020-09-11 | 厦门大学 | Construction method and application of escherichia coli engineering bacteria for producing protocatechuic acid |
CN111748508A (en) * | 2020-06-23 | 2020-10-09 | 厦门大学 | Construction method and application of escherichia coli with high yield of hydroxytyrosol |
CN112813013A (en) * | 2021-02-06 | 2021-05-18 | 江南大学 | Recombinant escherichia coli for producing hydroxytyrosol and application thereof |
CN112980711A (en) * | 2021-03-18 | 2021-06-18 | 陕西师范大学 | Construction method of recombinant yarrowia lipolytica for efficiently and completely synthesizing hydroxytyrosol by using strong promoter |
-
2022
- 2022-08-04 CN CN202210930591.7A patent/CN116064344B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104805110A (en) * | 2015-05-13 | 2015-07-29 | 中国科学院天津工业生物技术研究所 | Recombinant escherichia coli using glucose for producing hydroxytyrosol as well as recombination method and application |
CN108753636A (en) * | 2018-06-12 | 2018-11-06 | 山东恒鲁生物科技有限公司 | A kind of yeast and construction method producing tyrosol and hydroxytyrosol |
CN111647616A (en) * | 2020-06-23 | 2020-09-11 | 厦门大学 | Construction method and application of escherichia coli engineering bacteria for producing protocatechuic acid |
CN111748508A (en) * | 2020-06-23 | 2020-10-09 | 厦门大学 | Construction method and application of escherichia coli with high yield of hydroxytyrosol |
CN112813013A (en) * | 2021-02-06 | 2021-05-18 | 江南大学 | Recombinant escherichia coli for producing hydroxytyrosol and application thereof |
CN112980711A (en) * | 2021-03-18 | 2021-06-18 | 陕西师范大学 | Construction method of recombinant yarrowia lipolytica for efficiently and completely synthesizing hydroxytyrosol by using strong promoter |
Also Published As
Publication number | Publication date |
---|---|
CN116064344B (en) | 2024-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Xie et al. | The kinetic characterization of photofermentative bacterium Rhodopseudomonas faecalis RLD-53 and its application for enhancing continuous hydrogen production | |
JP2009538118A (en) | Enzymatic production of 2-hydroxy-2-methylcarboxylic acid | |
JP6444419B2 (en) | Sporolactobacillus terae and its use | |
CN103509729A (en) | Construction method of engineering bacterium for producing coenzyme Q10, engineering bacterium and application of engineering bacterium | |
CN105441371B (en) | A kind of genetic engineering bacterium and its application in production Co-Q10 | |
CN103509816A (en) | Coenzyme-Q10-production engineered bacteria construction method, engineered bacteria, and application thereof | |
CN112813013A (en) | Recombinant escherichia coli for producing hydroxytyrosol and application thereof | |
JP2023133181A (en) | Production methods of recombinant escherichia coli and high purity ursodeoxycholic acid | |
CN105219667B (en) | Bacterial strain and hydrogen production process for wood-sugar fermentation hydrogen manufacturing | |
CN112080452B (en) | High-yield phenyllactic acid bacillus licheniformis genetically engineered bacterium, method for producing phenyllactic acid and application | |
CN107435057B (en) | Method for producing hydroxyproline by adopting escherichia coli JL-HYP fermentation | |
CN116286560B (en) | Raoult bacterium HC6 and application thereof in low-temperature production of 2, 3-butanediol | |
CN116064344B (en) | Construction method and application of recombinant escherichia coli for producing hydroxytyrosol by fermentation | |
CN117603891A (en) | Lactococcus lactis for MK-n production and construction method and application thereof | |
Nair et al. | Production of poly-gamma-glutamic acid (γ-PGA) from sucrose by an osmotolerant Bacillus paralicheniformis NCIM 5769 and genome-based predictive biosynthetic pathway | |
CN107299074B (en) | Construction method and application of formate dehydrogenase engineering strain | |
CN114277068B (en) | Microbial fermentation preparation method of R-3-ethyl hydroxybutyrate | |
CN113493758B (en) | Tyrosol-producing recombinant escherichia coli capable of shortening fermentation period and application thereof | |
CN109628363B (en) | Engineering bacterium for producing high molecular weight hyaluronic acid and construction method and application thereof | |
CN117106836B (en) | Application of phosphatidyl glycerol phosphatase coding gene in fermentation production of cytidine | |
CN116904492B (en) | Rhodopseudomonas palustris capable of producing isoprene as well as construction method and application thereof | |
CN117946984B (en) | Pantothenate synthetase mutant and preparation method thereof, construction method thereof, pantothenate production strain and application thereof, and pantothenate preparation method | |
US20220002689A1 (en) | Feruloyl Esterase and Application thereof | |
CN111073830B (en) | Lactobacillus casei with high yield of gamma-glutamyltranspeptidase and application thereof in production of L-theanine | |
CN102321556B (en) | Aeromonas and application of aeromonas in biotransformation of (R)-alpha-hydroxyphenylacetic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant |